Mafalda Matos

Mafalda Matos

Auto-generated profile, based on publicly available information

Mafalda Matos

Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2015 in eLife
Verified
Journal Article
Open access
AGAna Rita Grosso
Ana Rita Grosso
ALAna P Leite
Ana P Leite
SCSílvia Carvalho
Sílvia Carvalho
MMMafalda R Matos
Mafalda R Matos
FMFilipa B Martins
Filipa B Martins
SASérgio Fernandes de Almeida
Sérgio Fernandes de Almeida
Aberrant expression of cancer genes and non-canonical RNA species is a hallmark of cancer. However, the mechanisms driving such atypical gene expression programs are incompletely understood. Here, our transcriptional profiling of a cohort of 50 primary clear cell renal cell carcinoma (ccRCC) samples from The Cancer Genome Atlas (TCGA) reveals that transcription read-through beyond the termination site is a source of transcriptome diversity in cancer cells. Amongst the genes most frequently mutated in ccRCC, we identified SETD2 inactivation as a potent enhancer of transcription read-through. We further show that invasion of neighbouring genes and generation of RNA chimeras are functional outcomes of transcription read-through. We identified the BCL2 oncogene as one of such invaded genes and detected a novel chimera, the CTSC-RAB38, in 20% of ccRCC samples. Collectively, our data highlight a novel link between transcription read-through and aberrant expression of oncogenes and chimeric transcripts that is prevalent in cancer.

10 May 2021 in Blood
Verified
Journal Article
Open access
PDF file
ASAna Silva
Ana Silva
AAAfonso Almeida
Afonso Almeida
ACAna Cachucho
Ana Cachucho
JNJoão L. Neto
João L. Neto
SDSofie Demeyer
Sofie Demeyer
João T BarataJoão T Barata
João T Barata
Tight regulation of IL-7Rα expression is essential for normal T-cell development. IL-7Rα gain-of-function mutations are known drivers of T-cell acute lymphoblastic leukemia (T-ALL). Although a subset of patients with T-ALL display high IL7R messenger RNA levels and cases with IL7R gains have been reported, the impact of IL-7Rα overexpression, rather than mutational activation, during leukemogenesis remains unclear. In this study, overexpressed IL-7Rα in tetracycline-inducible Il7r transgenic and Rosa26 IL7R knockin mice drove potential thymocyte self-renewal, and thymus hyperplasia related to increased proliferation of T-cell precursors, which subsequently infiltrated lymph nodes, spleen, and bone marrow, ultimately leading to fatal leukemia. The tumors mimicked key features of human T-ALL, including heterogeneity in immunophenotype and genetic subtype between cases, frequent hyperactivation of the PI3K/Akt pathway paralleled by downregulation of p27Kip1 and upregulation of Bcl-2, and gene expression signatures evidencing activation of JAK/STAT, PI3K/Akt/mTOR and Notch signaling. Notably, we also found that established tumors may no longer require high levels of IL-7R expression upon secondary transplantation and progressed in the absence of IL-7, but remain sensitive to inhibitors of IL-7R–mediated signaling ruxolitinib (Jak1), AZD1208 (Pim), dactolisib (PI3K/mTOR), palbociclib (Cdk4/6), and venetoclax (Bcl-2). The relevance of these findings for human disease are highlighted by the fact that samples from patients with T-ALL with high wild-type IL7R expression display a transcriptional signature resembling that of IL-7–stimulated pro-T cells and, critically, of IL7R-mutant cases of T-ALL. Overall, our study demonstrates that high expression of IL-7Rα can promote T-cell tumorigenesis, even in the absence of IL-7Rα mutational activation.

1 September 2015 in Neurobiology of Aging
Verified
Journal Article
Closed access
NKNiels Kruse
Niels Kruse
SPStaffan Persson
Staffan Persson
DADaniel Alcolea
Daniel Alcolea
JBJustyna M.C. Bahl
Justyna M.C. Bahl
IBInes Baldeiras
Ines Baldeiras
BMBrit Mollenhauer
Brit Mollenhauer

17 July 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Patricia AbrantesPatricia Abrantes
Patricia Abrantes
MSMaria M. Santos
Maria M. Santos
ISInês Sousa
Inês Sousa
JXJoana M. Xavier
Joana M. Xavier
VFVânia Francisco
Vânia Francisco
SOSofia A. Oliveira
Sofia A. Oliveira
Subarachnoid hemorrhage (SAH) is a life-threatening event that most frequently leads to severe disability and death. Its most frequent cause is the rupture of a saccular intracranial aneurysm (IA), which is a blood vessel dilation caused by disease or weakening of the vessel wall. Although the genetic contribution to IA is well established, to date no single gene has been unequivocally identified as responsible for IA formation or rupture. We aimed to identify IA susceptibility genes in the Portuguese population through a pool-based multistage genome-wide association study. Replicate pools were allelotyped in triplicate in a discovery dataset (100 IA cases and 92 gender-matched controls) using the Affymetrix Human SNP Array 6.0. Top SNPs (absolute value of the relative allele score difference between cases and controls |RASdiff|≥13.0%) were selected for technical validation by individual genotyping in the discovery dataset. From the 101 SNPs successfully genotyped, 99 SNPs were nominally associated with IA. Replication of technically validated SNPs was conducted in an independent replication dataset (100 Portuguese IA cases and 407 controls). rs4667622 (between UBR3 and MYO3B), rs6599001 (between SCN11A and WDR48), rs3932338 (214 kilobases downstream of PRDM9), and rs10943471 (96 kilobases upstream of HTR1B) were associated with IA (unadjusted allelic chi-square tests) in the datasets tested (discovery: 6.84E-04≤P≤1.92E-02, replication: 2.66E-04≤P≤2.28E-02, and combined datasets: 6.05E-05≤P≤5.50E-04). Additionally, we confirmed the known association with IA of rs1333040 at the 9p21.3 genomic region, thus validating our dataset. These novel findings in the Portuguese population warrant further replication in additional independent studies, and provide additional candidates to more comprehensively understand IA etiopathogenesis.

15 November 2011 in The Journal of Rheumatology
Verified
Journal Article
Closed access
PDF file
FPFernando Manuel Pimnetel-Santos
Fernando Manuel Pimnetel-Santos
DLDario Ligeiro
Dario Ligeiro
MMMafalda Matos
Mafalda Matos
AMAna Filipa Mourão
Ana Filipa Mourão
ESElsa Vieira de Sousa
Elsa Vieira de Sousa
TGThe CORPOREA Study Group
The CORPOREA Study Group
Objective.: Unconfirmed reports describe association of ankylosing spondylitis (AS) with several candidate genes includingANKH. Cellular export of inorganic pyrophosphate is regulated by the ANK protein, and mutant mice (ank/ank), which have a premature stop codon in the 3’ end of theankgene, develop severe ankylosis. We tested the association between single-nucleotide polymorphisms (SNP) in these genes and susceptibility to AS in a population of patients with AS. We investigated the role of these genes in terms of functional (BASFI) and metrological (BASMI) measures, and the association with radiological severity (mSASSS).Methods.: Our study was conducted on 355 patients with AS and 95 ethnically matched healthy controls. AS was defined according to the modified New York criteria. Four SNP inANKH(rs27356, rs26307, rs25957, and rs28006) were genotyped. Association analysis was performed using Cochrane-Armitage and linear regression tests for dichotomous and quantitative variables. Analyses of Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), BASFI, and mSASSS were controlled for sex and disease duration.Results.: None of the 4 markers showed significant single-locus disease associations (p > 0.05), suggesting thatANKHwas not a major determinant of AS susceptibility in our population. No association was observed between these SNP and age at symptom onset, BASDAI, BASFI, BASMI, or mSASSS.Conclusion.: These results confirm data in white Europeans thatANKHis probably not a major determinant of susceptibility to AS.ANKHpolymorphisms do not markedly influence AS disease severity, as measured by BASMI and mSASSS.

1 March 2014 in Annals of the Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
ACAna Luísa Cartaxo
Ana Luísa Cartaxo
Ines GodetInes Godet
Ines Godet
DLDário Ligeiro
Dário Ligeiro
MMMafalda Matos
Mafalda Matos
Jaime BrancoJaime Branco
Jaime Branco
FPFernando Manuel Pimnetel-Santos
Fernando Manuel Pimnetel-Santos
Background and Objectives Association between ankylosing spondylitis (AS) and PTPN1 (protein tyrosine phosphatase, non-receptor type 1) gene, was recently reported in Portuguese population, in a study of whole blood transcriptional profiling, performed by our group. Protein tyrosine phosphatase 1B (PTP1B) is a ubiquitously expressed enzyme shown to negatively regulate multiple tyrosine phosphorylation-dependent signalling pathways, including IL4 signalling and IL23 pathway (dephosphorylation of JAK2 and TYK2 kinases). In addition, several PTPN1 single nucleotide polymorphisms (SNPs), were significantly associated with coronary calcified plaque in type 2 Diabetes patients. We sought to test the association between SNPs in this gene and susceptibility to AS among a Portuguese population. In addition, we investigated the association of this gene with activity (BASDAI), functional (BASFI), metrological (BASMI) and radiological severity (mSASSS) indexes. Materials and Methods The study was conducted on 330 AS cases and 225 ethnically matched Portuguese healthy controls. AS was defined according to the modified New York Criteria. Genotyping of PTPN1 variants (rs2206656 and rs932420) was carried out with TaqMan allelic discrimination assays. Association analysis was performed using the Cochrane-Armitage and linear regression tests of genotypes as implemented in PLINK for dichotomous and quantitative variables respectively. Analyses of BASDAI, BASFI, BASMI and mSASSS were stratified for sex and disease duration. Results Two markers (rs2206656, rs932420) were analysed. None of them showed significant single-locus disease association (p > 0.05) with AS in the Portuguese population. No association was observed between these SNPs and BASDAI, BASFI, BASMI or mSASSS. Conclusions These results suggest that PTPN1, contrary to recently described for PTPN2, is probably not a major determinant of susceptibility to AS. In Portuguese population, PTPN1 polymorphisms do not markedly influence AS disease activity and severity, as measured by BASDAI, BASFI, BASMI and mSASSS.